[1] 张科,李春耕.中医药治疗结肠癌基础研究进展[J].国际中医中药杂志,2020,42(9):936-938.
ZHANG K,LI CG.Progress of the basic research on traditional Chinese medicine treating colon cancer[J].The International Journal of Traditional Chinese Medicine,2020,42(9):936-938.
[2] 王启龙,张春泽,张伟华.人参皂苷减轻结肠癌化疗副反应机制的研究进展[J].中医药信息,2019,36(5):128-131.
WANG QL,ZHANG CZ,ZHANG WH.Research progress on the mechanism of ginsenoside in alleviating side effects of chemotherapy in colon cancer[J].Information on Traditional Chinese Medicine,2019,36(5):128-131.
[3] SONG X,WANG L,FAN D.Insights into recent studies on biotransformation and pharmacological activities of ginsenoside Rd[J].Biomolecules,2022,12(4):512-546.
[4] PHI LTH,SARI IN,WIJAYA YT,et al.Ginsenoside Rd inhibits the metastasis of colorectal cancer via epidermal growth factor receptor signaling axis[J].IUBMB Life,2019,71(5):601-610.
[5] GU B,WANG J,SONG Y,et al.The inhibitory effects of ginsenoside Rd on the human glioma U251 cells and its underlying mechanisms[J].J Cell Biochem,2019,120(3):4444-4450.
[6] LIU GM,LU TC,SUN ML,et al.Ginsenoside Rd inhibits glioblastoma cell proliferation by up-regulating the expression of miR-144-5p[J].Biol Pharm Bull,2020,43(10):1534-1541.
[7] 彭志浩,李玉明.长链非编码RNA与结肠癌发生、发展关系的研究进展[J].医学研究杂志,2020,49(3):9-11,4.
PENG ZH,LI YM.Research progress on the relationship between long non-coding RNA and the occurrence and development of colon cancer[J].Journal of Medical Research,2020,49(3):9-11,4.
[8] GAO H,LI X,ZHAN G,et al.Long noncoding RNA MAGI1-IT1 promoted invasion and metastasis of epithelial ovarian cancer via the miR-200a/ZEB axis[J].Cell Cycle,2019,18(12):1393-1406.
[9] ZHANG Q,WANG F,WANG F,et al.Long noncoding RNA MAGI1-IT1 regulates cardiac hypertrophy by modulating miR-302e/DKK1/Wnt/beta-catenin signaling pathway[J].J Cell Physiol,2020,235(1):245-253.
[10] 白姣姣,阿丽亚·依拉木,阿布都艾则孜·艾尔肯,等.中药复方及单体治疗结肠癌药效与机制研究进展[J].中国实验方剂学杂志,2023,29(4):246-252.
BAI JJ,ALIYA E,ABDULAZIZ A,et al.Efficacy and mechanism of Chinese medicinal compounds and monomers from Chinese medicinals against colorectal cancer:A review[J].Chinese Journal of Experimental Traditional Medical Formulae,2023,29(4):246-252.
[11] WU CWK,REID M,LEEDHAM S,et al.The emerging era of personalized medicine in advanced colorectal cancer[J].J Gastroenterol Hepatol,2022,37(8):1411-1425.
[12] SUN X,HONG Y,SHU Y,et al.The involvement of Parkin-dependent mitophagy in the anti-cancer activity of Ginsenoside[J].J Ginseng Res,2022,46(2):266-274.
[13] TIAN YZ,LIU YP,TIAN SC,et al.Antitumor activity of ginsenoside Rd in gastric cancer via up-regulation of Caspase-3 and Caspase-9[J].Pharmazie,2020,75(4):147-150.
[14] CHIAN S,ZHAO Y,XU M,et al.Ginsenoside Rd reverses cisplatin resistance in non-small-cell lung cancer A549 cells by downregulating the nuclear factor erythroid 2-related factor 2 pathway[J].Anticancer Drugs,2019,30(8):838-845.
[15] YANG X,GAO M,MIAO M,et al.Combining combretastatin A4 phosphate with ginsenoside Rd synergistically inhibited hepatocellular carcinoma by reducing HIF-1α via PI3K/AKT/mTOR signalling pathway[J].J Pharm Pharmacol,2021,73(2):263-271.
[16] ZHANG G,CHEN HX,YANG SN,et al.MAGI1-IT1 stimulates proliferation in non-small cell lung cancer by upregulating AKT1 as a ceRNA[J].Eur Rev Med Pharmacol Sci,2020,24(2):691-698.